Andrea Mafficini

ARC-Net Research Centre, University and hospital trust of Verona

Affiliated withUniversity and hospital trust of Verona

Research Area

Biography

Andrea Mafficini has not added Biography.
If you are Andrea Mafficini and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2019

Other Publications

Article	Year
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association\| PubMed ID: 24272205	2014
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. The Journal of pathology\| PubMed ID: 24604757	2014
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. Virchows Archiv : an international journal of pathology\| PubMed ID: 24828033	2014
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups. Oncotarget\| PubMed ID: 24867389	2014
Reporting tumor molecular heterogeneity in histopathological diagnosis. PloS one\| PubMed ID: 25127237	2014
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components. Neuroendocrinology\| PubMed ID: 25342539	2014
Impact of MIF gene promoter polymorphism on F508del cystic fibrosis patients. PloS one\| PubMed ID: 25503271	2014
Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium. BMC cancer\| PubMed ID: 25637035	2015
Next-generation sequencing for genetic testing of familial colorectal cancer syndromes. Hereditary cancer in clinical practice\| PubMed ID: 26300997	2015
A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics. Cancer discovery\| PubMed ID: 26446169	2015
New genomic landscapes and therapeutic targets for biliary tract cancers. Frontiers in bioscience (Landmark edition)\| PubMed ID: 26709801	2016
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing. Oncotarget\| PubMed ID: 26745875	2016
Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 a... The Journal of pathology\| PubMed ID: 27873319	2017
Whole-genome landscape of pancreatic neuroendocrine tumours. Nature\| PubMed ID: 28199314	2017
Fhit down-regulation is an early event in pancreatic carcinogenesis. Virchows Archiv : an international journal of pathology\| PubMed ID: 28289900	2017
Splice variants as novel targets in pancreatic ductal adenocarcinoma. Scientific reports\| PubMed ID: 28592875	2017
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients. Journal of hematology & oncology\| PubMed ID: 28637510	2017
Non-coding regulatory variations: the dark matter of pancreatic cancer genomics. Gut\| PubMed ID: 28659348	2018
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma. The Journal of pathology\| PubMed ID: 28722124	2017
Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium. The Journal of endocrinology\| PubMed ID: 29321190	2018
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm. Virchows Archiv : an international journal of pathology\| PubMed ID: 29388013	2018
Frequent fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression. Oncotarget\| PubMed ID: 29515761	2018
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma. Scientific reports\| PubMed ID: 29740198	2018
PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications. Human pathology\| PubMed ID: 30031096	2018
Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study. BMC cancer\| PubMed ID: 30115026	2018
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance. Pathology, research and practice\| PubMed ID: 30190183	2018
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine. Virchows Archiv : an international journal of pathology\| PubMed ID: 30219970	2018
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas. The Journal of pathology\| PubMed ID: 30306561	2019
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis. Pancreas\| PubMed ID: 30451797	2019
Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms. Endocrine reviews\| PubMed ID: 30657883	2019
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer\| PubMed ID: 31085341	2019
Ultra-Mutation in Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment. Cancers\| PubMed ID: 31480372	2019